Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis
- PMID: 27048634
- PMCID: PMC4823436
- DOI: 10.1136/bmjopen-2015-009986
Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis
Abstract
Objective: To assess the effects of use of cannabis during pregnancy on maternal and fetal outcomes.
Data sources: 7 electronic databases were searched from inception to 1 April 2014. Studies that investigated the effects of use of cannabis during pregnancy on maternal and fetal outcomes were included.
Study selection: Case-control studies, cross-sectional and cohort studies were included.
Data extraction and synthesis: Data synthesis was undertaken via systematic review and meta-analysis of available evidence. All review stages were conducted independently by 2 reviewers.
Main outcomes and measures: Maternal, fetal and neonatal outcomes up to 6 weeks postpartum after exposure to cannabis. Meta-analyses were conducted on variables that had 3 or more studies that measured an outcome in a consistent manner. Outcomes for which meta-analyses were conducted included: anaemia, birth weight, low birth weight, neonatal length, placement in the neonatal intensive care unit, gestational age, head circumference and preterm birth.
Results: 24 studies were included in the review. Results of the meta-analysis demonstrated that women who used cannabis during pregnancy had an increase in the odds of anaemia (pooled OR (pOR)=1.36: 95% CI 1.10 to 1.69) compared with women who did not use cannabis during pregnancy. Infants exposed to cannabis in utero had a decrease in birth weight (low birth weight pOR=1.77: 95% CI 1.04 to 3.01; pooled mean difference (pMD) for birth weight=109.42 g: 38.72 to 180.12) compared with infants whose mothers did not use cannabis during pregnancy. Infants exposed to cannabis in utero were also more likely to need placement in the neonatal intensive care unit compared with infants whose mothers did not use cannabis during pregnancy (pOR=2.02: 1.27 to 3.21).
Conclusions and relevance: Use of cannabis during pregnancy may increase adverse outcomes for women and their neonates. As use of cannabis gains social acceptance, pregnant women and their medical providers could benefit from health education on potential adverse effects of use of cannabis during pregnancy.
Keywords: PREVENTIVE MEDICINE; PUBLIC HEALTH.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Figures
Similar articles
-
Use of cannabis during pregnancy and birth outcomes in an Aboriginal birth cohort: a cross-sectional, population-based study.BMJ Open. 2016 Feb 23;6(2):e010286. doi: 10.1136/bmjopen-2015-010286. BMJ Open. 2016. PMID: 26908527 Free PMC article.
-
Neonatal outcomes associated with in utero cannabis exposure: a population-based retrospective cohort study.Am J Obstet Gynecol. 2024 Jul;231(1):132.e1-132.e13. doi: 10.1016/j.ajog.2023.11.1232. Epub 2023 Nov 27. Am J Obstet Gynecol. 2024. PMID: 38029850
-
Birth Outcomes of Neonates Exposed to Marijuana in Utero: A Systematic Review and Meta-analysis.JAMA Netw Open. 2022 Jan 4;5(1):e2145653. doi: 10.1001/jamanetworkopen.2021.45653. JAMA Netw Open. 2022. PMID: 35084479 Free PMC article.
-
Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. PMID: 24783270 Free Books & Documents. Review.
-
Birth, cognitive and behavioral effects of intrauterine cannabis exposure in infants and children: A systematic review and meta-analysis.Addiction. 2024 Mar;119(3):411-437. doi: 10.1111/add.16370. Epub 2023 Nov 15. Addiction. 2024. PMID: 37968824 Review.
Cited by
-
Cannabis Use During Early Pregnancy Following Recreational Cannabis Legalization.JAMA Health Forum. 2024 Nov 1;5(11):e243656. doi: 10.1001/jamahealthforum.2024.3656. JAMA Health Forum. 2024. PMID: 39485336 Free PMC article.
-
Cannabis Use during Pregnancy: An Update.Medicina (Kaunas). 2024 Oct 15;60(10):1691. doi: 10.3390/medicina60101691. Medicina (Kaunas). 2024. PMID: 39459478 Free PMC article. Review.
-
Prenatal cannabis exposure in the clinic and laboratory: What do we know and where do we need to go?Drug Alcohol Depend Rep. 2024 Sep 18;13:100282. doi: 10.1016/j.dadr.2024.100282. eCollection 2024 Dec. Drug Alcohol Depend Rep. 2024. PMID: 39430603 Free PMC article. Review.
-
Maternal Prenatal Cannabis Use and Child Autism Spectrum Disorder.JAMA Netw Open. 2024 Oct 1;7(10):e2440301. doi: 10.1001/jamanetworkopen.2024.40301. JAMA Netw Open. 2024. PMID: 39422906 Free PMC article.
-
The Liberalization of Cannabis Possession Laws and Birth Outcomes: A State-Level Fixed Effects Analysis, 2003-2019.Popul Res Policy Rev. 2022 Aug;41(4):1809-1829. doi: 10.1007/s11113-022-09714-6. Epub 2022 Apr 11. Popul Res Policy Rev. 2022. PMID: 39421565 Free PMC article.
References
-
- WHO. Management of substance abuse: Cannabis. 7 July 2015. http://www.who.int/substance_abuse/facts/cannabis/en/
-
- Crime, U.N.O.o.D.a. World drug report. 2014. http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf
-
- Board, I.N.C, U.N.V.I. Centre, and Austria. International Narcotics Control Board: 2013 Annual Report, 2013.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous